STOCK TITAN

Alkermes to Participate in the Stifel Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced participation in a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, at 8:00 a.m. ET. The live webcast will be accessible on the company's website and archived for 14 days.

Alkermes is a global biopharmaceutical company focused on developing innovative treatments in neuroscience and oncology, with products aimed at alcohol and opioid dependence, schizophrenia, and bipolar disorder.

Positive
  • None.
Negative
  • None.

DUBLIN, Nov. 8, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on Tuesday, Nov. 15, 2022 at 8:00 a.m. ET (1:00 p.m. GMT). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Sandy Coombs
Investor Relations
+1 781 609 6377

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-stifel-healthcare-conference-301672166.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Stifel Healthcare Conference?

Alkermes will participate in the Stifel Healthcare Conference on November 15, 2022, at 8:00 a.m. ET.

How can I access the Alkermes fireside chat webcast?

The webcast for the Alkermes fireside chat can be accessed under the Investors tab on Alkermes' website.

What is the focus of Alkermes as a biopharmaceutical company?

Alkermes develops innovative medicines primarily in the fields of neuroscience and oncology.

What products does Alkermes offer for addiction treatment?

Alkermes has products focused on alcohol and opioid dependence.

Where is Alkermes headquartered?

Alkermes is headquartered in Dublin, Ireland.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4